Geofract
Experienced member
- Messages
- 1,483
- Likes
- 112
hello
Greeting from “Sunny England”
I haven’t disappeared (sorry for you!!! Lol) but as you know between olives before and packing after I have been too busy to post and trade (did some in USA only)
I don’t expect to do much trading before Xmas because the wife will do shopping shopping and shopping (she say it is cheaper in England… easier to say that with my wallet…. grrr …. LOL
Hope you all doing well and keep nice and warm….. (bloody freezing IMO):cheesy:
Greeting from “Sunny England”
I haven’t disappeared (sorry for you!!! Lol) but as you know between olives before and packing after I have been too busy to post and trade (did some in USA only)
I don’t expect to do much trading before Xmas because the wife will do shopping shopping and shopping (she say it is cheaper in England… easier to say that with my wallet…. grrr …. LOL
Hope you all doing well and keep nice and warm….. (bloody freezing IMO):cheesy:
hey fellas, apologies for sort of abandoning the thread...think i've dropped the ball re trying to trade.
seasons greetings to everyone, hope you all have a great 2010!
all the best
You'll pick the ball up again Dr B, no worries mate, all the best for the new year.
Wishing everyone a successful and profitable 2010
good morning
hope you all have had a nice Xmas....
while I am waiting my party to get ready to go to York shopping (can't understand wamen that never get tired of shopping....then they got the nerve to say "I don't have anything to wear!!!!!" ... grrrr lol
I was looking at the markets (the English is close (?)) but the rest is on the positive ...(new high?)
in the UK keep an eye on IFL OXF NVR (but DYOR) + funcy put few ££ on LLOY
NVR 24/12/2009 7:00am
RESTORATION OF TRADING ON AIM
Oxford, UK - 15 December 2009: Oxford BioMedica (LSE: OXB), a leading gene therapy company,
announced today that StarGen, the Company's gene-based therapy for Stargardt disease, has received orphan designation from the Committee for Orphan Medicinal Products of the European Medicines Agency (EMEA). Stargardt disease is a hereditary disorder of the eye that is caused by abnormalities in a gene called ABCA4 in the retina. StarGen is designed to deliver a corrected version of the ABCA4 gene into the cells of the retina using the Company's LentiVector® technology. In collaboration with sanofi-aventis, clinical development is expected to start in 2010. The US charity, Foundation Fighting Blindness, is also supporting the programme and previously funded the preclinical development.
The EMEA grants orphan drug designation to products that may provide a significant advantage over current treatments, if any exist, for life-threatening or chronically debilitating conditions affecting up to five in 10,000 people in the European Union. Companies with European orphan drug designation benefit from incentives, including ten years of marketing exclusivity and reduced regulatory fees.
The trading on AIM for the under-mentioned securities was temporarily suspended. The suspension is lifted from 24/12/2009 7:00am, an announcement having been made and a document published.
hace a nice day
hope you all have had a nice Xmas....
while I am waiting my party to get ready to go to York shopping (can't understand wamen that never get tired of shopping....then they got the nerve to say "I don't have anything to wear!!!!!" ... grrrr lol
I was looking at the markets (the English is close (?)) but the rest is on the positive ...(new high?)
in the UK keep an eye on IFL OXF NVR (but DYOR) + funcy put few ££ on LLOY
NVR 24/12/2009 7:00am
RESTORATION OF TRADING ON AIM
Oxford, UK - 15 December 2009: Oxford BioMedica (LSE: OXB), a leading gene therapy company,
announced today that StarGen, the Company's gene-based therapy for Stargardt disease, has received orphan designation from the Committee for Orphan Medicinal Products of the European Medicines Agency (EMEA). Stargardt disease is a hereditary disorder of the eye that is caused by abnormalities in a gene called ABCA4 in the retina. StarGen is designed to deliver a corrected version of the ABCA4 gene into the cells of the retina using the Company's LentiVector® technology. In collaboration with sanofi-aventis, clinical development is expected to start in 2010. The US charity, Foundation Fighting Blindness, is also supporting the programme and previously funded the preclinical development.
The EMEA grants orphan drug designation to products that may provide a significant advantage over current treatments, if any exist, for life-threatening or chronically debilitating conditions affecting up to five in 10,000 people in the European Union. Companies with European orphan drug designation benefit from incentives, including ten years of marketing exclusivity and reduced regulatory fees.
The trading on AIM for the under-mentioned securities was temporarily suspended. The suspension is lifted from 24/12/2009 7:00am, an announcement having been made and a document published.
hace a nice day
hey fellas, apologies for sort of abandoning the thread...think i've dropped the ball re trying to trade.
seasons greetings to everyone, hope you all have a great 2010!
all the best
hello dr.blix
looking forward to your input...
when ever I get down I think that health it is more important althought money help but isn't everything JMO..... how many would like to be in my position and be very happy why am I sad then?.... that cheer me up so to speak.....
take care
'grats on the new 6 month contract Geo
Equities only eh ? so you think it's that easy to leave the dark side do ya ?
hey fellas, apologies for sort of abandoning the thread...think i've dropped the ball re trying to trade.
seasons greetings to everyone, hope you all have a great 2010!
all the best
Don't worry , all need a rest from it now and again.
so you got a plan for 2010 ?
Hope everyone had a good crimbo.
So far santa brought me , rabid flue 2 weeks before as a stocking filler , followed a few days after I got over that by a dose of norovirus as the big prezzie.
So Yea , cheers you hairy old git, so gonna kick your **** when you come snooping round next year
So far santa brought me , rabid flue 2 weeks before as a stocking filler , followed a few days after I got over that by a dose of norovirus as the big prezzie.
So Yea , cheers you hairy old git, so gonna kick your **** when you come snooping round next year
dr.blix
Senior member
- Messages
- 2,279
- Likes
- 33
hey mas, my plan is to give myself a month of properly trialling the bias retracement method. incredibly it's something i've still not yet done. if i can't do this then i think it's time to call it a day, as i obviously don't have the patience or discipline to do it.
let the experiment begin! :cheesy:
